default author photo

Benjamin J. Solomon

Peter MacCallum Cancer Centre

305 Grattan Street

Parkville

Melbourne

Australia

SCHOLARLY PAPERS

2

DOWNLOADS

116

TOTAL CITATIONS

1

Scholarly Papers (2)

1.

Tiragolumab Plus Atezolizumab Versus Placebo Plus Atezolizumab in Patients with Previously Untreated PD-L1-High, Locally Advanced Unresectable or Metastatic NSCLC (SKYSCRAPER-01): A Phase 3, Randomised, Double-Blind, Placebo-Controlled Study

Number of pages: 36 Posted: 19 Sep 2025
Centre Hospitalier Universitaire Vaudois (CHUV), Yale University, National Cancer Center Hospital, University Hospital 12 de Octubre, Sarah Cannon Research Institute, Peter MacCallum Cancer Centre, Istanbul Medeniyet University, Hacettepe University, Dniprovsky State Medical University, Seoul National University - Department of Internal Medicine, Hospital Vall d’Hebron, Istituto Nazionale Tumori - IRCCS Fondazione G. Pascale, E.J. Zeyland Wielkopolska Center of Pulmonology and Thoracic Surgery, Matrahaza University, National Cancer Center Hospital East, German Centre for Lung Research - Lungen Clinic Grosshansdorf, Genentech, Inc. - San Francisco, Genentech, Inc. - San Francisco, Genentech, Inc. - San Francisco, Genentech, Inc. - San Francisco, Genentech, Inc. - San Francisco, Genentech, Inc. - San Francisco, Genentech, Inc. - San Francisco, Genentech, Inc. - San Francisco and Yonsei University - Yonsei Cancer Center
Downloads 84 (790,029)

Abstract:

Loading...

Non-small cell lung cancer, NSCLC, immune checkpoint inhibitors, anti-TIGIT monoclonal antibody, PD-L1 inhibitor, atezolizumab, tiragolumab, cancer immunotherapy

2.

Completion Of Pembrolizumab In Advanced Non-Small Cell Lung Cancer – Real World Outcomes After Two Years of Therapy (Copilot)

Number of pages: 13 Posted: 11 Jan 2024
Fiona Stanley Hospital, Fiona Stanley Hospital, Peter MacCallum Cancer Centre, Peter MacCallum Cancer Centre, The University of Sydney - Westmead Hospital, The University of Sydney - Westmead Hospital, The University of Sydney, The University of Sydney, Royal North Shore Hospital, The University of Sydney, The University of Sydney and Sir Charles Gairdner Hospital
Downloads 32 (1,290,922)
Citation 1

Abstract:

Loading...

Lung cancer, Immunotherapy, pembrolizumab, Real world outcomes